A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors
Clinical trial NCT00586092 · COMPLETED
Trial details
- NCT number
- NCT00586092
- Sponsor
- Herbert Hurwitz
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2013-02-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.